LENZ - LENZ Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$12.00
DETAILS
HIGH:
$12.00
LOW:
$12.00
MEDIAN:
$12.00
CONSENSUS:
$12.00
UPSIDE:
58.94%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Revenue | 19.1 | 0 | 0 | 15 | 0 | 0 | 0 |
| Cost of Revenue | 0.7 | 0.1 | 0 | 0 | 0.7 | 0.1 | 0 |
| Gross Profit | 18.4 | (0.1) | 0 | 15 | (0.7) | (0.1) | 0 |
| Operating Expenses | |||||||
| R&D Expenses | 18.7 | 29.8 | 59.5 | 21.1 | 37.9 | 9.1 | 0 |
| SG&A Expenses | 90.9 | 28.8 | 12.9 | 4.4 | 21.8 | 4.3 | 0.0 |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 109.5 | 58.6 | 72.4 | 25.5 | 59.7 | 13.4 | 0.0 |
| Operating Income | |||||||
| Operating Income | (91.1) | (58.6) | (72.4) | (10.5) | (60.4) | (13.5) | (0.0) |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0.0 | 0.1 |
| Interest Income | 9.8 | 8.6 | 2.2 | 0 | 0 | 0 | 0 |
| Profitability | |||||||
| EBITDA | (90.9) | (49.7) | (72.4) | (10.5) | (70.0) | (68.2) | 0.1 |
| EBIT | (91.1) | (49.8) | (72.4) | (10.5) | (70.8) | (68.3) | (0.0) |
| Income Before Tax | (81.6) | (49.8) | (70.1) | (10.5) | (70.8) | (68.4) | (0.1) |
| Income Tax Expense | 0.5 | 0.0 | (0.2) | 0.3 | 0 | 0 | 0 |
| Net Income | (82.1) | (49.8) | (70.0) | (10.8) | (70.8) | (68.4) | (0.1) |
| Per Share Data | |||||||
| EPS (Basic) | -2.85 | -2.34 | -15.30 | -12.89 | -8.54 | -8.24 | -0.01 |
| EPS (Diluted) | -2.85 | -2.34 | -15.30 | -12.89 | -8.54 | -8.24 | -0.01 |
| Shares Outstanding | 28.8 | 21.3 | 8.1 | 7.8 | 8.3 | 8.3 | 8.3 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Current Assets | |||||||
| Cash & Cash Equivalents | 25.2 | 20.2 | 35.1 | 44.4 | 18.3 | 19.8 | 0.0 |
| Short-Term Investments | 267.2 | 188.9 | 30.7 | 0 | 0 | 0 | 0 |
| Net Receivables | 2.4 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | (2.4) | 0.1 | 1.4 | 2.2 | 0.0 | 1.3 | 0 |
| Total Current Assets | 292.3 | 211.9 | 67.2 | 46.6 | 18.3 | 21.1 | 0.0 |
| Non-Current Assets | |||||||
| Property, Plant & Equipment | 0 | 2.0 | 0.4 | 0.3 | 0.0 | 1.5 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 13.5 | 1.4 | 2.8 | 0.0 | 0.0 | 0 | 0 |
| Total Non-Current Assets | 13.5 | 3.4 | 3.1 | 0.3 | 0.0 | 1.5 | 0 |
| Total Assets | 305.9 | 215.3 | 70.4 | 47.0 | 18.3 | 22.6 | 0.0 |
| Current Liabilities | |||||||
| Account Payables | 4.2 | 4.3 | 5.7 | 4.8 | 0.5 | 0.6 | 0 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 2.2 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 17.0 | 0 | 0 | 0 | 0 | 31.0 | 0.0 |
| Total Current Liabilities | 21.2 | 10.4 | 18.5 | 9.5 | 1.3 | 32.0 | 2.2 |
| Non-Current Liabilities | |||||||
| Long-Term Debt | 0.3 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 144.4 | 61.5 | 31.3 | 0.3 | 0 |
| Total Non-Current Liabilities | 0.3 | 0.8 | 144.6 | 61.6 | 31.3 | 0.3 | 0 |
| Total Liabilities | 21.5 | 11.2 | 163.1 | 71.1 | 32.5 | 32.4 | 2.2 |
| Stockholders' Equity | |||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0 | 0 |
| Retained Earnings | (227.1) | (145.0) | (95.2) | (25.3) | (14.5) | (70.6) | (2.2) |
| Accumulated Other Comprehensive Income | 0.2 | 0.2 | 0.0 | 0 | 0 | 0 | 0 |
| Total Stockholders' Equity | 284.3 | 204.1 | (92.7) | (24.2) | (14.2) | (9.8) | (2.2) |
| Total Liabilities & Equity | 305.9 | 215.3 | 70.4 | 47.0 | 18.3 | 22.6 | 0.0 |
| Debt Metrics | |||||||
| Total Debt | 0.3 | 1.4 | 0.3 | 0.2 | 0 | 0 | 2.2 |
| Net Debt | (24.8) | (18.8) | (34.8) | (44.2) | (18.3) | (19.8) | 2.2 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | (82.1) | (49.8) | (70.0) | (101.1) | (70.8) | (68.4) | (0.1) |
| Depreciation & Amortization | (3.1) | 0.1 | 0.0 | 8.3 | 0.7 | 0.1 | 0 |
| Stock-Based Compensation | 12.5 | 6.4 | 1.3 | 0 | 0 | 0 | 0 |
| Change in Working Capital | 3.3 | (13.1) | 9.4 | (7.2) | (2.5) | 1.7 | 0.0 |
| Other Non-Cash Items | 0.3 | (3.0) | (1.2) | 11.9 | 19.7 | 57.8 | 0.1 |
| Operating Cash Flow | (69.2) | (59.4) | (60.4) | (88.0) | (52.9) | (8.7) | (0.0) |
| Investing Activities | |||||||
| Capital Expenditure | (0.8) | (0.5) | (0.0) | (6.6) | (5.7) | (1.5) | 0 |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | (280.8) | (241.9) | (52.1) | (405.5) | 0 | 0 | 0 |
| Sales/Maturities of Investments | 206.0 | 87.9 | 22.5 | 170.2 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (75.7) | (154.5) | (29.6) | (241.9) | (5.7) | (1.5) | 0 |
| Financing Activities | |||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Repurchased | 0 | 0 | 0 | (0.1) | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 119.5 | (2.3) | 0 | 0.3 | 0 | 0 |
| Financing Cash Flow | 149.7 | 199.0 | 80.7 | 0.6 | 417.5 | 30.1 | 0 |
| Cash Position | |||||||
| Net Change in Cash | 4.9 | (14.9) | (9.3) | (329.2) | 357.2 | 19.8 | 0.0 |
| Cash at Beginning | 20.3 | 35.1 | 44.4 | 377.0 | 19.8 | 0.0 | 0 |
| Cash at End | 25.2 | 20.3 | 35.1 | 47.7 | 377.0 | 19.8 | 0.0 |
| Free Cash Flow | (70.0) | (59.9) | (60.4) | (94.6) | (58.6) | (10.3) | (0.0) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 19.1 | 0 | 0 | 15 | 0 | 0 | 0 |
| Gross Profit | 18.4 | (0.1) | 0 | 15 | (0.7) | (0.1) | 0 |
| Operating Income | (91.1) | (58.6) | (72.4) | (10.5) | (60.4) | (13.5) | (0.0) |
| Net Income | (82.1) | (49.8) | (70.0) | (10.8) | (70.8) | (68.4) | (0.1) |
| EPS (Diluted) | -2.85 | -2.34 | -15.30 | -12.89 | -8.54 | -8.24 | -0.01 |
| Balance Sheet | |||||||
| Cash & Equivalents | 25.2 | 20.2 | 35.1 | 44.4 | 18.3 | 19.8 | 0.0 |
| Total Assets | 305.9 | 215.3 | 70.4 | 47.0 | 18.3 | 22.6 | 0.0 |
| Total Debt | 0.3 | 1.4 | 0.3 | 0.2 | 0 | 0 | 2.2 |
| Stockholders' Equity | 284.3 | 204.1 | (92.7) | (24.2) | (14.2) | (9.8) | (2.2) |
| Cash Flow | |||||||
| Operating Cash Flow | (69.2) | (59.4) | (60.4) | (88.0) | (52.9) | (8.7) | (0.0) |
| Capital Expenditure | (0.8) | (0.5) | (0.0) | (6.6) | (5.7) | (1.5) | 0 |
| Free Cash Flow | (70.0) | (59.9) | (60.4) | (94.6) | (58.6) | (10.3) | (0.0) |